Can I take metoprolol while pregnant or breastfeeding?

A plain-words look at what the NHS, the US drug label and LactMed say about metoprolol.

In short

Pregnancy: Metoprolol can be taken while you're pregnant.

Breastfeeding: If your baby is healthy and you need a medicine for high blood pressure, metoprolol is one of the best options while breastfeeding, but speak to your doctor or pharmacist first.

Your doctor, midwife or pharmacist can help you decide.

What this means for you

Pregnancy

Breastfeeding

When to get help

Talk to your doctor or pharmacist

This page is educational, not advice for your own situation. Talk to your doctor, midwife or pharmacist before you start, stop or change any medicine in pregnancy or while breastfeeding.

The details: what each source says

Metoprolol in pregnancy

The NHS says

Metoprolol can be taken while you're pregnant. If you take it for heart problems, you'll probably be advised to carry on taking it through pregnancy.

Metoprolol can sometimes affect how your baby grows, so you'll need extra growth scans (usually from 32 weeks) to keep a check on this.

If you're trying for a baby or are already pregnant, ask your doctor whether metoprolol is the right medicine for you.

In our words, from the NHS page Metoprolol (nhs.uk). Contains public sector information licensed under the Open Government Licence v3.0 (OGL v3.0). The NHS does not endorse this site.

The US drug label says

8.1 Pregnancy Risk Summary Untreated hypertension and heart failure during pregnancy can lead to adverse outcomes for the mother and the fetus (see Clinical Considerations). Available data from published observational studies have not demonstrated a drug-associated risk of major birth defects, miscarriage, or adverse maternal or fetal outcomes with metoprolol use during pregnancy. However, there are inconsistent reports of intrauterine growth restriction, preterm birth, and perinatal mortality with maternal use of beta-blockers, including metoprolol, during pregnancy (see Data). In animal reproduction studies, metoprolol has been shown to increase post-implantation loss and decrease neonatal survival in rats at oral dosages of 500 mg/kg/day, approximately 24 times the daily dose of 200 mg in a 60-kg patient on a mg/m 2 basis. The estimated background risk of major birth defects and miscarriage for the indicated population is unknown. All pregnancies have a background risk of birth defect, loss, or other adverse outcomes.

Prescribing label, section “8.1 Pregnancy” (opening excerpt): Metoprolol Succinate (oral), Granules India Ltd. Read the full section on DailyMed. Quoted verbatim; US labels are written for US prescribers and patients.

More on metoprolol in pregnancy: Bumps (Best Use of Medicines in Pregnancy) leaflet (external site).

Metoprolol while breastfeeding

The NHS says

If your baby is healthy and you need a medicine for high blood pressure, metoprolol is one of the best options while breastfeeding, but speak to your doctor or pharmacist first.

Very small amounts of metoprolol get into breast milk. It has not been known to cause side effects in breastfed babies.

Carrying on with metoprolol is important to keep you well, and breastfeeding also has benefits for both you and your baby.

Side effects in breastfed babies from medicines their mother takes are very rare. Even so, it's important to keep an eye on your baby while you take any medicine and breastfeed.

Contact a healthcare professional or call 111 (in the UK) as soon as you can if your baby: is not feeding as well as they usually do or not gaining weight as expected; seems unusually sleepy, tired or weak; is much paler than normal; seems sweaty or shaky; or has changes in their breathing.

If your baby has any other symptoms, or you're worried about them, you can still call 111 or get in touch with any healthcare professional.

In our words, from the NHS page Metoprolol (nhs.uk). Contains public sector information licensed under the Open Government Licence v3.0 (OGL v3.0). The NHS does not endorse this site.

LactMed says

Because of the low levels of metoprolol in breastmilk, amounts ingested by the infant are small and would not be expected to cause any adverse effects in breastfed infants. Studies on the use of metoprolol during breastfeeding have found no adverse reactions in breastfed infants. Monitor breastfed infants for symptoms of beta blockade such as bradycardia and listlessness due to hypoglycemia.

“Summary of Use during Lactation”, LactMed record “Metoprolol” (LM296), quoted verbatim. Everything LactMed reports about Metoprolol while breastfeeding.

The US prescribing label says

8.2 Lactation Risk Summary Limited available data from published literature report that metoprolol is present in human milk. The estimated daily infant dose of metoprolol received from breastmilk ranges from 0.05 mg to less than 1 mg. The estimated relative infant dosage was 0.5% to 2% of the mother's weight-adjusted dosage (see Data). No adverse reactions of metoprolol on the breastfed infant have been identified. There is no information regarding the effects of metoprolol on milk production. Clinical consideration Monitoring for adverse reactions Monitor the breastfed infant for bradycardia and other symptoms of beta-blockade such as listlessness (hypoglycemia). Data Based on published case reports, the estimated infant daily dose of metoprolol received from breast milk range from 0.05 mg to less than 1 mg. The estimated relative infant dosage was 0.5% to 2% of the mother’s weight-adjusted dosage. In two women who were taking unspecified amount of metoprolol, milk samples were taken after one dose of metoprolol. The estimated amount of metoprolol and alpha-hydroxy metoprolol in breast milk is reported to be less than 2% of the mother's weight-adjusted dosage.

Prescribing label, section “8.2 Lactation” (opening excerpt): Metoprolol Succinate (oral), Granules India Ltd. Read the full section on DailyMed. Quoted verbatim; US labels are written for US prescribers and patients.

Sources

  1. NHS, Metoprolol (nhs.uk), page last reviewed 20 January 2026. Paraphrased. Contains public sector information licensed under the Open Government Licence v3.0.
  2. US drug label: Metoprolol Succinate (oral), Granules India Ltd, human prescription drug, label effective 4 September 2026, set ID c5431c8a-d92c-489e-b63b-4b9cc8f32a1a. DailyMed (National Library of Medicine). Public domain; quoted verbatim.
  3. Drugs and Lactation Database (LactMed), National Institute of Child Health and Human Development (NICHD), via NCBI Bookshelf, record “Metoprolol” (LM296), bulk release of 22 September 2026. LactMed on NCBI Bookshelf. Public domain; quoted verbatim. LactMed is a registered trademark of the U.S. Department of Health and Human Services.
  4. Bumps (Best Use of Medicines in Pregnancy), UK Teratology Information Service: Bumps (Best Use of Medicines in Pregnancy) leaflet. Linked, not reproduced.

Sources checked 26 September 2026. How we source and check every page.

Educational summary of named sources, not medical advice.